NeoStem, Inc. (NBS) Receives Second-Year NIAID Grant Award for Developing VSEL Technology to Treat Radiation Exposure
Today, cellular therapy leader NeoStem announced that the National Institute of Allergy and Infectious Diseases (NIAID), a division of the…